Serum Parathyroid Hormone Is a New Potential Risk Factor in Multiple Myeloma
Figure 3
Impact of PTH on clinical outcome. Kaplan-Meier curves of overall survival (OS) and progression-free survival (PFS) stratified by PTH level for all patients (a-b), PFS of patients on complete remission state at the end-point of present study (c), PFS of patients with ISS stage II (d), PFS of patients with no chromosome abnormality (e), and PFS of patients who have undergone stem cell transplantation (f).
